Copyright
©The Author(s) 2025.
World J Cardiol. Feb 26, 2025; 17(2): 103273
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.103273
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.103273
Table 1 Baseline characteristics of the study population, n (%)
Characteristics | RA < 3.84 (n = 739) | RA 3.84-4.66 (n = 736) | RA > 4.66 (n = 743) | P value |
RA | 3.45 ± 0.28 | 4.20 ± 0.23 | 5.89 ± 1.37 | < 0.001 |
Clinical parameters | ||||
Age, years | 63.86 ± 15.31 | 70.18 ± 14.98 | 70.36 ± 14.75 | < 0.001 |
Gender | < 0.001 | |||
Male | 510 (69.01) | 393 (53.40) | 404 (54.37) | |
Female | 229 (30.99) | 343 (46.60) | 339 (45.63) | |
Ethnicity | 0.038 | |||
White | 497 (67.25) | 523 (71.06) | 510 (68.64) | |
Black | 46 (6.22) | 54 (7.34) | 69 (9.29) | |
Other | 196 (26.52) | 159 (21.60) | 164 (22.07) | |
Vital signs | ||||
MAP, mmHg | 80.33 ± 10.91 | 77.51 ± 11.50 | 74.03 ± 11.40 | < 0.001 |
Heart rate, times/minute | 79.21 ± 15.91 | 80.94 ± 15.62 | 85.06 ± 17.20 | < 0.001 |
RR, times/minute | 18.52 ± 3.44 | 19.30 ± 3.88 | 19.67 ± 4.23 | < 0.001 |
Temperature, °C | 36.79 ± 0.60 | 36.79 ± 0.75 | 36.68 ± 0.82 | 0.001 |
SpO2, % | 97.19 ± 1.79 | 96.89 ± 2.58 | 96.87 ± 3.65 | 0.047 |
Comorbidities | ||||
CHF | 163 (22.06) | 256 (34.78) | 241 (32.44) | < 0.001 |
Atrial fibrillation | 190 (25.71) | 271 (36.82) | 303 (40.78) | < 0.001 |
COPD | 15 (2.03) | 19 (2.58) | 12 (1.62) | 0.425 |
CAD | 477 (64.55) | 435 (59.10) | 348 (46.84) | < 0.001 |
Pulmonary circulation | 122 (16.51) | 192 (26.09) | 264 (35.53) | < 0.001 |
Renal failure | 73 (9.88) | 155 (21.06) | 199 (26.78) | < 0.001 |
Laboratory parameters | ||||
Albumin, g/dL | 3.93 ± 0.33 | 3.44 ± 0.29 | 2.87 ± 0.51 | < 0.001 |
Serum creatinine, mg/dL | 1.17 ± 1.17 | 1.51 ± 1.34 | 2.04 ± 1.82 | < 0.001 |
Glucose, mg/dL | 121.72 ± 41.36 | 119.21 ± 39.28 | 113.50 ± 45.35 | < 0.001 |
Serum urea nitrogen, mg/dL | 21.15 ± 16.61 | 29.52 ± 20.64 | 38.54 ± 27.38 | < 0.001 |
Hematocrit, % | 34.03 ± 5.84 | 31.13 ± 5.19 | 29.03 ± 5.35 | < 0.001 |
Hemoglobin, g/dL | 11.75 ± 2.05 | 10.56 ± 1.79 | 9.64 ± 1.75 | < 0.001 |
WBC, 109/L | 9.97 ± 3.80 | 10.27 ± 4.35 | 11.17 ± 6.79 | 0.158 |
Platelet, 109/L | 210.02 ± 68.56 | 213.47 ± 88.36 | 216.30 ± 105.17 | 0.722 |
RDW, fl | 13.52 ± 0.88 | 14.43 ± 1.18 | 16.41 ± 2.24 | < 0.001 |
Sodium, mmol/L | 136.35 ± 4.25 | 136.19 ± 4.96 | 135.86 ± 5.63 | 0.030 |
Potassium, mmol/L | 3.73 ± 0.48 | 3.79 ± 0.54 | 3.84 ± 0.64 | 0.002 |
INR | 1.27 ± 0.48 | 1.42 ± 0.69 | 1.60 ± 0.85 | < 0.001 |
PT, second | 14.09 ± 3.93 | 15.33 ± 5.56 | 16.54 ± 6.09 | < 0.001 |
Scoring system | ||||
SOFA | 3.21 ± 2.58 | 4.24 ± 2.96 | 5.67 ± 3.41 | < 0.001 |
Primary outcome | ||||
365-day mortality | 96 (12.99) | 172 (23.37) | 307 (41.32) | < 0.001 |
Secondary outcomes | ||||
30-day mortality | 54 (7.31) | 93 (12.64) | 167 (22.48) | < 0.001 |
90-day mortality | 70 (9.47) | 120 (16.30) | 218 (29.34) | < 0.001 |
Hospital LOS, day | 7.12 ± 6.53 | 9.42 ± 9.55 | 11.84 ± 11.05 | < 0.001 |
CCU LOS, day | 3.69 ± 4.29 | 4.76 ± 6.34 | 5.88 ± 7.41 | < 0.001 |
Table 2 The β value or hazard ratios or odds ratio for outcomes across groups of red blood cell distribution width-to-albumin ratios (95% confidence interval)
Mortality | Non-adjusted, HR | Non-adjusted, P value | Adjust I, HR | Adjust I, P value | Adjust II, HR | Adjust II, P value | PSM, OR | PSM, P value |
365-day all-cause mortality | ||||||||
RA | 1.18 (1.12, 1.25) | < 0.001 | 1.20 (1.13, 1.26) | < 0.001 | 1.08 (1.01, 1.15) | 0.026 | 1.24 (1.10, 1.41) | < 0.001 |
Tertiles < 3.84 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
Tertiles 3.84-4.66 | 1.09 (0.85, 1.41) | 0.478 | 1.09 (0.85, 1.40) | 0.499 | 1.02 (0.79, 1.34) | 0.859 | 1.28 (0.87, 1.87) | 0.209 |
Tertiles > 4.66 | 1.62 (1.29, 2.03) | < 0.001 | 1.65 (1.31, 2.08) | < 0.001 | 1.30 (1.01, 1.69) | 0.045 | 1.92 (1.28, 2.89) | 0.002 |
30-day all-cause mortality | ||||||||
RA | 1.14 (1.06, 1.22) | < 0.001 | 1.16 (1.08, 1.24) | < 0.001 | 1.01 (0.93, 1.10) | 0.839 | ||
Tertiles < 3.84 | 1.00 | 1.00 | 1.00 | |||||
Tertiles 3.84-4.66 | 1.03 (0.74, 1.44) | 0.863 | 1.05 (0.75, 1.48) | 0.765 | 0.99 (0.68, 1.43) | 0.944 | ||
Tertiles > 4.66 | 1.40 (1.03, 1.90) | 0.032 | 1.45 (1.06, 1.97) | 0.019 | 1.06 (0.73, 1.52) | 0.770 | ||
90-day all-cause mortality | ||||||||
RA | 1.17 (1.10, 1.25) | < 0.001 | 1.19 (1.12, 1.27) | < 0.001 | 1.05 (0.97, 1.13) | 0.198 | ||
Tertiles < 3.84 | 1.00 | 1.00 | 1.00 | |||||
Tertiles 3.84-4.66 | 1.02 (0.76, 1.37) | 0.879 | 1.03 (0.77, 1.39) | 0.837 | 0.96 (0.70, 1.32) | 0.795 | ||
Tertiles > 4.66 | 1.45 (1.11, 1.89) | 0.007 | 1.49 (1.14, 1.95) | 0.004 | 1.10 (0.81, 1.50) | 0.545 | ||
Hospital LOS, β, days | ||||||||
RA | 1.70 (1.41, 1.99) | < 0.001 | 1.76 (1.46, 2.06) | < 0.001 | 1.20 (0.85, 1.55) | < 0.001 | ||
Tertiles < 3.84 | 0.00 | 0.00 | 0.00 | |||||
Tertiles 3.84-4.66 | 2.30 (1.36, 3.24) | < 0.001 | 2.54 (1.58, 3.51) | < 0.001 | 1.54 (0.52, 2.56) | 0.003 | ||
Tertiles > 4.66 | 4.72 (3.77, 5.66) | < 0.001 | 4.98 (4.02, 5.94) | < 0.001 | 2.73 (1.61, 3.85) | < 0.001 | ||
CCU LOS, β, days | ||||||||
RA | 0.66 (0.47, 0.86) | < 0.001 | 0.72 (0.52, 0.92) | < 0.001 | 0.23 (0.00, 0.46) | 0.047 | ||
Tertiles < 3.84 | 0.00 | 0.00 | 0.00 | |||||
Tertiles 3.84-4.66 | 1.07 (0.44, 1.70) | < 0.001 | 1.23 (0.59, 1.87) | < 0.001 | 0.67 (0.00, 1.34) | 0.049 | ||
Tertiles > 4.66 | 2.20 (1.57, 2.82) | < 0.001 | 2.37 (1.73, 3.01) | < 0.001 | 0.80 (0.06, 1.53) | 0.034 |
- Citation: Wang JN, Hu ZS, Yu YW, Peng XH. Red blood cell distribution width to albumin ratio is correlated with prognosis of patients in coronary care unit. World J Cardiol 2025; 17(2): 103273
- URL: https://www.wjgnet.com/1949-8462/full/v17/i2/103273.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i2.103273